XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism Jul 20, 2016 9:00am EDT
XOMA Reports First Quarter 2016 Operational Achievements and Financial Results May 04, 2016 4:01pm EDT
XOMA Initiates XOMA 358 Proof-of-Concept Study in Patients with Hypoglycemia Post Gastric Bypass Surgery Apr 27, 2016 9:00am EDT
XOMA Presented First Data from Novel Antibody Fragment to Address Severe Acute Hypoglycemia at the ENDO Meeting Apr 04, 2016 9:00am EDT
XOMA to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Webcast on March 9 Feb 24, 2016 1:29pm EST
